Immune response following infection with SARS‐CoV ‐2 and other coronaviruses: A rapid review-Reference-Cited by-同舟云学术

Immune response following infection with SARS‐CoV ‐2 and other coronaviruses: A rapid review

Published:2020-09-23 Issue:2 Volume:31 Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev Med Virol

Author:

O Murchu Eamon¹²^ORCID,Byrne Paula¹,Walsh Kieran A.¹,Carty Paul G.¹,Connolly Máire³,De Gascun Cillian⁴,Jordan Karen¹,Keoghan Mary⁵,O'Brien Kirsty K.¹,O'Neill Michelle¹,Smith Susan M.⁶,Teljeur Conor¹,Ryan Máirín¹⁷,Harrington Patricia¹

Affiliation:

1. Health Technology Assessment Directorate Health Information and Quality Authority Dublin 7 Ireland

2. The Centre for Health Policy and Management Trinity College Dublin Dublin 2 Ireland

3. School of Medicine National University of Ireland Galway Galway Ireland

4. UCD National Virus Reference Laboratory University College Dublin Dublin 4 Ireland

5. Department of Clinical Immunology Beaumont Hospital Dublin 9 Ireland

6. Department of General Practice, Health Research Board Centre for Primary Care Research Royal College of Surgeons in Ireland Dublin 2 Ireland

7. Department of Pharmacology & Therapeutics, Trinity Health Sciences Trinity College Dublin Dublin 8 Ireland

Funder

Health Research Board

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2162

Reference124 articles.

1. HIQA. Health Information and Quality Authority. Protocol for evidence synthesis support ‐ COVID‐19.https://www.hiqa.ie/sites/default/files/2020‐05/Protocol‐for‐HIQA‐COVID‐19‐evidence‐synthesis‐support_1‐6.pdf.2020. Accessed June 1 2020.

2. GarrittyC GartlehnerG KamelCet al.Cochrane Rapid Reviews. Interim Guidance from the Cochrane Rapid Reviews Methods Group; March2020.

3. WellsGA SheaB O'ConnellD et al. The Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses.http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed August 14 2020.

4. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

5. AdamsER AnandR AnderssonMI et al. Evaluation of antibody testing for SARS‐Cov‐2 using ELISA and lateral flow immunoassays.medRxiv. 2020. doi:https://doi.org/10.1101/2020.04.15.20066407.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk assessment of infection of COVID‐19 contacts based on scenario simulation;Risk Analysis;2024-07-29

2. Immunity testing against COVID-19 from blood by an IoT-enabled and AI-controlled multiplexed microfluidic platform;Biosensors and Bioelectronics;2024-01

3. Longitudinal anti-SARS-CoV-2 antibody immune response in acute and convalescent patients;Frontiers in Cellular and Infection Microbiology;2023-09-08

4. SARS-CoV-2 infections in “less visible” hospital staff: The roles and safety of environmental services and allied health professionals;Journal of Infection and Public Health;2023-09

5. Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands;Influenza and Other Respiratory Viruses;2023-08